Introducing Prevora – a clinically proven, long-lasting antibacterial coating designed to protect high-risk adult patients from tooth decay.
The antibacterial solution, now launching in the UK, drew strong interest throughout the two days at Dentistry Show London, with live demonstrations showing how Prevora works by managing oral dysbiosis that contributes to both caries and gum disease.
With more than 20 years of clinical research and real-world use in North America, Prevora (pictured above) offers UK dental teams a powerful new option to reduce the bacterial burden driving caries and periodontal disease.
Containing 10% chlorhexidine, Prevora is applied quickly and painlessly to the teeth and gums, forming a long-acting protective barrier that helps rebalance the oral microbiome. The innovative two-step process – applying a chlorhexidine coating followed by an inert sealant – was demonstrated to delegates across the show.
The product is supported by a growing body of expert opinion. Following the first in a series of advisory boards led by Prevolution Health (exclusive UK distributors of Prevora), leading experts including Professors Iain Chapple and Avijit Banerjee are helping to shape its clinical integration and patient impact.
Dr Ben Atkins, past-president of the Oral Health Foundation, founder of Revive Dental Care and a clinician advisor for NICE, explained during the show:
‘Prevora could be a crucial tool for hard-to-treat and high-risk patients, addressing this ever-growing market. It offers significant benefits for those who struggle with persistent dental issues and are at higher risk of complications. Prevora could also improve NHS dentistry by providing effective preventive care and reducing the burden on dental services.’
A targeted preventive option
Prevora is licensed for the prevention of tooth decay in high-risk adults, including those with:
- A history of caries or bleeding gums
- Diabetes or dry mouth
- Dental implants or pre-implant procedures
- Difficulty maintaining hygiene routines
- Polypharmacy, social care residency or complex needs.
Applied by dental hygienists, dental therapists or dental nurses (under the supervision of a GDC registrant) in under 10 minutes, Prevora integrates easily into hygiene appointments. Its non-invasive, painless application makes it well-suited to patients seeking less complex care, without compromising effectiveness.
By incorporating Prevora into routine hygiene appointments, practices can enhance clinical outcomes for high-risk adults while reducing reliance on restorative interventions. Delegates also heard how this approach increases hygiene appointment value and profitability, offering a commercially attractive option in line with growing demand for proactive oral healthcare.
Strong presence at Dentistry Show London
At Dentistry Show London, the Prevolution Health team welcomed hundreds of visitors keen to explore Prevora, review the supporting scientific evidence, and learn how easily it can be integrated into practice. A highlight of the event was the well-attended panel discussion on ‘Managing the complex needs of high-risk patients’, hosted by Dr Ben Atkins and featuring Professors Iain Chapple and Tim Newton in the Clinical Excellence Theatre.
For more information on the launch, visit www.prevora.co.uk/professional and follow Prevolution Health on Linkedin and Instagram.
This article is sponsored by Prevolution Health.
